Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Other Operating Expenses (2020 - 2025)

INVO Fertility (IVF) has disclosed Other Operating Expenses for 8 consecutive years, with -$13.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to -$13.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$16.9 million, a 177.68% decrease, with the full-year FY2024 number at -$21.5 million, down 90.36% from a year prior.
  • Other Operating Expenses was -$13.7 million for Q3 2025 at INVO Fertility, down from $2.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $15.9 million in Q1 2025 to a low of -$21.6 million in Q4 2024.
  • A 5-year average of -$1.4 million and a median of -$2431.0 in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: plummeted 84525.46% in 2022, then soared 16710.37% in 2025.
  • INVO Fertility's Other Operating Expenses stood at -$11432.0 in 2021, then soared by 2155.97% to $235038.0 in 2022, then plummeted by 2731.47% to -$6.2 million in 2023, then crashed by 249.72% to -$21.6 million in 2024, then surged by 36.77% to -$13.7 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Other Operating Expenses are -$13.7 million (Q3 2025), $2.5 million (Q2 2025), and $15.9 million (Q1 2025).